INDICATIONS AND USAGE

Teriflunomide tablet is indicated for the treatment of  relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults.

DOSAGE

The recommended dose of teriflunomide tablet is 7 mg or 14 mg orally once daily. Teriflunomide tablet can be taken with or without food.

ADVERSE REACTIONS

Hepatotoxicity

Bone Marrow Effects /Immunosuppression Potential/Infections

Hypersensitivity Reactions

Serious Skin Reactions

Drug Reaction with Eosinophilia and Systemic Symptoms

Peripheral Neuropathy

Increased Blood Pressure

Respiratory Effects

For full information, please refer to:

https://nctr-crs.fda.gov/fdalabel/services/spl/set-ids/63ba28ef-5055-461a-99ef-c49e8ece4b54/spl-doc?hl=Teriflunomide

Denopsyinformation